The complete genomic information within a sample or individual is known as the whole genome. Exons are the genome's protein-coding regions and are collectively known as the exome. Despite the exome's relatively small proportion of the whole genome (approximately 2%), exomes encode most known disease-related variants.
Explore the benefits of both approaches to understand which method is best for your research.Download Infographic
Read how whole-genome sequencing can capture important information in the nucleosome to reveal genes that drive metastatic cancers.
See how combining whole-genome and exome sequencing can yield important insights into variants related to autoimmune disorders such as lupus.
Learn how adopting the DRAGEN Bio-IT Platform can help you scale up your whole-genome sequencing needs with accuracy and reliability.
Learn how whole-genome sequencing is gaining momentum for precision diagnosis to improve future clinical care.
Discover how Dr. Kristen Brennand incorporates whole-genome and exome sequencing to reveal complex disease pathways and phenotypes in neuropsychiatric disease.
Read more about how a comprehensive view of the genome enables efficient discovery of important variants and novel genome assembly.
When whole-genome sequencing is not needed, explore how exome sequencing can provide a cost-effective and more accessible way to manage data for quicker analysis.
Discover how the power of next-generation sequencing (NGS) can reveal genomic and transcriptomic information in a scalable and high-throughput format.
A fast, integrated workflow for a wide range of applications, from human whole-genome sequencing to amplicons, plasmids, and microbial species.
Perform accurate, ultra-rapid secondary analysis of sequencing data.
Scalable throughput and flexibility for virtually any genome, sequencing method, and scale of project.